P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 05/09/24
P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference CallBusiness Wire • 05/02/24
P3 Health Partners Inc. (PIII) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/01/24
P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare ConferenceBusiness Wire • 04/03/24
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024Business Wire • 03/15/24
P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor ForumBusiness Wire • 03/07/24
P3 Health Partners to Participate in the Jefferies Value Based Healthcare SummitBusiness Wire • 02/28/24
P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare ConferenceBusiness Wire • 02/19/24
P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness Wire • 01/30/24
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024Business Wire • 01/10/24
P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/02/24
P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference CallBusiness Wire • 11/03/23
P3 Health Partners to Participate in the Lake Street Best Ideas Growth ConferenceBusiness Wire • 09/05/23